Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TG Therapeutics Inc (TGTX) vs Unity Software Inc (U) Price & Performance

TG Therapeutics IncTrade
Unity Software IncTrade

Price performance (Past 24H)

Key statistics

TG Therapeutics Inc vs Unity Software Inc — how do they compare? TG Therapeutics Inc trades at $49.7 (market cap $7.64B), while Unity Software Inc trades at $43.38 (market cap $19.31B). The key difference: Unity Software Inc is far larger — about 2.5× TG Therapeutics Inc's market cap, and Unity Software Inc is trading nearer its 52-week high, TG Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

TGTXU
Market Cap
$7.64B$19.31B
Sector
HealthTechnology
52-Week High
$59.06$49.47
52-Week Low
$26.94$17.13
Enterprise Value
$7.84B$19.19B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

TG Therapeutics Inc

No Aura AI signal available yet.

Unity Software Inc

Unity Software (U) trades at $43.10, up 0.23% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $47.45. Recent Q2 2026 earnings beat expectations, with revenue growth of 24% year-over-year, driven by strong Vector advertising platform performance. The company reported positive operating cash flow of $422.96 million in 2025, though net income remains negative at -$402.77 million.

The outlook is mixed: strong revenue growth and analyst optimism support upside potential, but persistent net losses and high valuation ratios (P/S 9.33, EV/EBITDA 134.62) pose risks. Investors should weigh the company's path to GAAP profitability against competitive pressures in the software sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About TG Therapeutics Inc

TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.

Read more on TGTX

About Unity Software Inc

Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.

Read more on U